Cardiac Diabetic Medicine Manufacturer in India— The cardiac and diabetic medicine manufacturers in India are high in demand as cardiovascular diseases such as diabetes are among the leading causes of death in the country. The need for cardiac and diabetic medications in India is amplified by the growing prevalence of these chronic conditions. This high demand for life-saving drugs presents an immense opportunity for manufacturers to contribute significantly to improving national health standards.
With an overwhelming proportion of the population either diagnosed with or at risk of developing these diseases, there is a strong demand for both preventive and therapeutic medications. The evolving treatment landscape also required manufacturers to continuously innovate and produce a wide range of medicines that cater to the diverse needs of patients. Khushru Medicare is a leading cardiac diabetic medicine manufacturer in India and also offers top PCD pharma franchise opportunities to investors and businessmen.
Growing Demand for Cardiac and Diabetic Medicines
The demand for cardiac and diabetic medicines is rapidly increasing as the global prevalence of cardiovascular diseases and diabetes continues to rise. Factors such as aging populations, unhealthy dietary habits, and sedentary lifestyles are contributing to the higher incidence of these chronic conditions. As a result, there is a growing need for effective treatments to manage and prevent complications associated with heart disease and diabetes. With improved patient awareness and early diagnosis, the accessibility and need for these medicines are expected to keep growing, ensuring better health outcomes worldwide.
Key Features:
- Need for effective management of heart disease and diabetes.
- Combination therapies enhance treatment efficiency and compliance.
- Personalized treatments reduce side effects and improve outcomes.
- Offers long-term benefits in preventing complications.
- Provides innovation in drug formulations and delivery systems.
- Increased availability and affordability of generic options.
- The ongoing research offers better therapeutic solutions.
- Improves patient convenience with extended-release medications.
Well Developed Manufacturing Facility
Khushru Medicare takes pride in its well-developed manufacturing facility, which is equipped with state-of-the-art technology to ensure the highest standards of quality and precision. The facility adheres to international GMP, ensuring that all products are manufactured under stringent quality control systems. With a focus on innovation and efficiency, the manufacturing unit plays a pivotal role in producing effective and reliable cardiac and diabetic medicines, meeting the growing demands of the healthcare sector.
Key Highlights
- State-of-the-art equipment and infrastructure.
- Compliance with international GMP standards.
- Stringent quality control procedures.
- Capacity for large-scale production.
- Continuous research and technological advancements.
- Focus on product safety and efficacy.
- Ensuring timely delivery and supply chain efficiency.
Tablets Range Offered by Khushru Medicare
Khushru Medicare offers a wide range of high-quality pharmaceutical tablets designed to address various health needs. Their product portfolio includes tablets for conditions such as pain management, antibiotics, vitamins and supplements, cardiovascular health, and digestive care. Each tablet is formulated to meet rigorous standards, ensuring efficacy and safety for patients. Here are the tablets provided by Khushru Medicare:
| Formulation (Medications + Dosage) | Indications |
|---|---|
| Ramipril 2.5 mg | Hypertension, heart failure, post-myocardial infarction |
| Ramipril 10 mg | Hypertension, heart failure, post-myocardial infarction |
| Ramipril 10 mg + Hydrochlorothiazide 12.5 mg | Hypertension, edema |
| Rosuvastatin Calcium 5 mg | Hyperlipidemia, cardiovascular disease prevention |
| Rosuvastatin Calcium 10 mg | Hyperlipidemia, cardiovascular disease prevention |
| Rosuvastatin Calcium 5 mg + Fenofibrate (Micronised) 67 mg | Hyperlipidemia, mixed dyslipidemia |
| Rosuvastatin Calcium 10 mg + Fenofibrate (Micronised) 160 mg | Hyperlipidemia, mixed dyslipidemia |
| Pioglitazone Hydrochloride 15 mg + Metformin Hydrochloride (SR) 500 mg | Type 2 Diabetes Mellitus |
| Pioglitazone Hydrochloride 15 mg | Type 2 Diabetes Mellitus |
| Pioglitazone Hydrochloride 30 mg | Type 2 Diabetes Mellitus |
| Pioglitazone Hydrochloride 30 mg + Metformin Hydrochloride (SR) 500 mg | Type 2 Diabetes Mellitus |
| Propranolol Hydrochloride 10 mg | Hypertension, arrhythmias, anxiety disorders |
| Propranolol Hydrochloride 20 mg | Hypertension, arrhythmias, anxiety disorders |
| Propranolol Hydrochloride 40 mg | Hypertension, arrhythmias, anxiety disorders |
| Prasugrel Hydrochloride 5 mg | Antiplatelet therapy (acute coronary syndrome, stent placement) |
| Prasugrel Hydrochloride 10 mg | Antiplatelet therapy (acute coronary syndrome, stent placement) |
| Olmesartan Medoxomil 40 mg + Amlodipine Besylate 5 mg | Hypertension |
| Olmesartan Medoxomil 20 mg + Amlodipine Besylate 5 mg | Hypertension |
| Olmesartan Medoxomil 20 mg + Metoprolol Succinate (ER) 50 mg | Hypertension, heart failure |
| Olmesartan Medoxomil 20 mg + Metoprolol Succinate (ER) 25 mg | Hypertension, heart failure |
| Olmesartan Medoxomil 20 mg | Hypertension |
| Olmesartan Medoxomil 40 mg | Hypertension |
| Olmesartan Medoxomil 20 mg + Hydrochlorothiazide 12.5 mg | Hypertension |
| Olmesartan Medoxomil 40 mg + Hydrochlorothiazide 12.5 mg | Hypertension |
| Nebivolol Hydrochloride 2.5 mg | Hypertension, heart failure |
| Nebivolol Hydrochloride 5 mg | Hypertension, heart failure |
| Metoprolol Succinate 25 mg + Amlodipine Besylate 2.5 mg | Hypertension, angina |
| Metoprolol Succinate 50 mg + Amlodipine Besylate 5 mg | Hypertension, angina |
| Metformin Hydrochloride (SR) 500 mg | Type 2 Diabetes Mellitus |
| Metformin Hydrochloride (SR) 1000 mg | Type 2 Diabetes Mellitus |
| Metoprolol Tartrate 25 mg | Hypertension, arrhythmias, heart failure |
| Metoprolol Tartrate 50 mg | Hypertension, arrhythmias, heart failure |
| Losartan Potassium 50 mg + Amlodipine Besylate 5 mg | Hypertension |
| Losartan Potassium 25 mg | Hypertension, diabetic nephropathy |
| Losartan Potassium 50 mg | Hypertension, diabetic nephropathy |
| Losartan Potassium 50 mg + Hydrochlorothiazide 12.5 mg | Hypertension |
| Glimepiride 3 mg | Type 2 Diabetes Mellitus |
| Glimepiride 4 mg | Type 2 Diabetes Mellitus |
| Isoxsuprine Hydrochloride 40 mg | Peripheral vascular diseases, vasodilation |
| Irbesartan 150 mg | Hypertension, diabetic nephropathy |
| Irbesartan 150 mg + Hydrochlorothiazide 12.5 mg | Hypertension |
| Isosorbide Mononitrate 20 mg | Angina, heart failure |
| Indapamide 1.5 mg | Hypertension, edema |
| Glimepiride 1 mg + Metformin Hydrochloride (SR) 500 mg + Pioglitazone Hydrochloride 7.5 mg | Type 2 Diabetes Mellitus |
| Glimepiride 2 mg + Metformin Hydrochloride (SR) 500 mg + Pioglitazone Hydrochloride 7.5 mg | Type 2 Diabetes Mellitus |
| Glimepiride 1 mg + Metformin Hydrochloride (SR) 1000 mg | Type 2 Diabetes Mellitus |
| Glimepiride 2 mg + Metformin Hydrochloride (SR) 1000 mg | Type 2 Diabetes Mellitus
|
Why Khushru Medicare is the Best Cardiac diabetic medicine Manufacturer in India?
Khushru Medicare is considered one of the best cardiac and diabetic medicine manufacturers in India due to its commitment to high-quality production, innovative formulations, and a patient-centric approach. The company combines advanced technology with rigorous research and development to create effective medications that cater to the needs of cardiac and diabetic patients. Their products are widely trusted for their reliability, safety, and efficacy, making them a top choice in the pharmaceutical industry.
Key Features:
- Adheres to strict manufacturing and quality control protocols.
- Focuses on advanced research to create effective treatments.
- Offers a wide array of medicines for cardiac and diabetic care.
- Prioritizes patient health and well-being in every product.
- Known for reliability and efficacy in the healthcare sector.
Contact At Phone numbers: 01792-230786, 01792-292286, +91- 8219716180, +91-8263885578
Email: khushrumedicare@gmail.com, aatif.khushru@gmail.com, sales.khushru@gmail.com
Corporate office: Khushru House, Khata No 613/846, Bawra Road Basal Patti, Kather Chambaghat, Industrial Area Solan, H.P 173213.
Factory Address: Hilltop, Industrial Estate, Vill.-Bhatauli Kalan, Tehsil Baddi, Distt. Solan [H.P.] –173205
